The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Respiratory Syncytial Virus Diagnostics Market Research Report 2025
Synopsis
Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
The global Respiratory Syncytial Virus Diagnostics market was valued at US$ 564.4 million in 2023 and is anticipated to reach US$ 837.1 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostics.
Report Scope
The Respiratory Syncytial Virus Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Syncytial Virus Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Syncytial Virus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion
Segment by Type
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Segment by Application
Hospitals
Laboratory
Clinics
Homecare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
The global Respiratory Syncytial Virus Diagnostics market was valued at US$ 564.4 million in 2023 and is anticipated to reach US$ 837.1 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostics.
Report Scope
The Respiratory Syncytial Virus Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Syncytial Virus Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Respiratory Syncytial Virus Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Fujirebio
Grifols
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
Roche Diagnostics
Scienion
Segment by Type
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Segment by Application
Hospitals
Laboratory
Clinics
Homecare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Direct Fluorescent Antibody Method
1.2.3 Rapid Antigen Diagnostic Tests
1.2.4 Molecular Diagnostics
1.2.5 Chromatographic Immunoassay
1.2.6 Diagnostic Imaging
1.2.7 Gel Microdroplets
1.2.8 Flow Cytometry
1.2.9 Other
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Clinics
1.3.5 Homecare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2019-2030)
2.2 Respiratory Syncytial Virus Diagnostics Growth Trends by Region
2.2.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Syncytial Virus Diagnostics Market Dynamics
2.3.1 Respiratory Syncytial Virus Diagnostics Industry Trends
2.3.2 Respiratory Syncytial Virus Diagnostics Market Drivers
2.3.3 Respiratory Syncytial Virus Diagnostics Market Challenges
2.3.4 Respiratory Syncytial Virus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
3.4 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2023
3.5 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Diagnostics Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2025-2030)
5 Respiratory Syncytial Virus Diagnostics Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2019-2030)
6.2 North America Respiratory Syncytial Virus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2019-2024)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2019-2030)
7.2 Europe Respiratory Syncytial Virus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2019-2024)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size (2019-2030)
9.2 Latin America Respiratory Syncytial Virus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Detail
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.1.5 Becton Dickinson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter/Danaher
11.4.1 Beckman Coulter/Danaher Company Detail
11.4.2 Beckman Coulter/Danaher Business Overview
11.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
11.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.4.5 Beckman Coulter/Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Detail
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Coris BioConcept
11.6.1 Coris BioConcept Company Detail
11.6.2 Coris BioConcept Business Overview
11.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
11.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.6.5 Coris BioConcept Recent Development
11.7 DiaSorin SPA
11.7.1 DiaSorin SPA Company Detail
11.7.2 DiaSorin SPA Business Overview
11.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
11.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.7.5 DiaSorin SPA Recent Development
11.8 Eiken Chemical
11.8.1 Eiken Chemical Company Detail
11.8.2 Eiken Chemical Business Overview
11.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
11.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.8.5 Eiken Chemical Recent Development
11.9 Elitech
11.9.1 Elitech Company Detail
11.9.2 Elitech Business Overview
11.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
11.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.9.5 Elitech Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Detail
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
11.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.10.5 Fujirebio Recent Development
11.11 Grifols
11.11.1 Grifols Company Detail
11.11.2 Grifols Business Overview
11.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
11.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.11.5 Grifols Recent Development
11.12 Hoffmann La Roche
11.12.1 Hoffmann La Roche Company Detail
11.12.2 Hoffmann La Roche Business Overview
11.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
11.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.12.5 Hoffmann La Roche Recent Development
11.13 Hologic
11.13.1 Hologic Company Detail
11.13.2 Hologic Business Overview
11.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
11.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.13.5 Hologic Recent Development
11.14 Novartis Diagnostics
11.14.1 Novartis Diagnostics Company Detail
11.14.2 Novartis Diagnostics Business Overview
11.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.14.5 Novartis Diagnostics Recent Development
11.15 Ortho Clinical Diagnostics
11.15.1 Ortho Clinical Diagnostics Company Detail
11.15.2 Ortho Clinical Diagnostics Business Overview
11.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.15.5 Ortho Clinical Diagnostics Recent Development
11.16 Roche Diagnostics
11.16.1 Roche Diagnostics Company Detail
11.16.2 Roche Diagnostics Business Overview
11.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.16.5 Roche Diagnostics Recent Development
11.17 Scienion
11.17.1 Scienion Company Detail
11.17.2 Scienion Business Overview
11.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
11.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2019-2024)
11.17.5 Scienion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
